Literature DB >> 21938196

A cross-sectional study to detect the prevalence of hyperhomocysteinemia in cases of deep vein thrombosis.

Gautam V Kamat1, S C Metgud, Vishwanath M Pattanshetti, A S Godhi.   

Abstract

Hyperhomocysteinemia is a known risk factor for the development of deep vein thrombosis (DVT). Various studies have been conducted in the western countries to know the prevalence of hyperhomocysteinemia in patients with DVT and in general population. There is no documented literature of the prevalence of hyperhomocysteinemia in Indian population. Thus the aim of this study was to determine the prevalence of hyperhomocysteinemia in cases of DVT in our population. To evaluate the prevalence of hyperhomocysteinemia, a prospective cross sectional study done on a total of 70 patients admitted in KLES Dr Prabhakar Kore hospital, Belgaum, India. DVT was confirmed by Doppler examination. Serum homocysteine was measured and the data analysed. Statistical significance was calculated using chi square test. A total of 70 patients were studied of which 53 were males and 17 were females. The prevalence of hyperhomocysteinemia among the cases of DVT was 31.428%.The prevalence among males was 35.85% and among females was 17.64%.There was statistically significant association between hyperhomocysteinemia and presence of ischaemic heart disease with a p value of 0.005 on chi square analysis. The prevalence of hyperhomocysteinemia in cases of deep vein thrombosis in our population was 31.428%. There was a statistically significant association between hyperhomocysteinemia and ischaemic heart disease.

Entities:  

Keywords:  Deep vein thrombosis; Hyperhomocyteinemia

Year:  2010        PMID: 21938196      PMCID: PMC3002777          DOI: 10.1007/s12262-010-0194-1

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  14 in total

1.  Treatment of hyperhomocysteinemia with folic acid and vitamins B12 and B6 attenuates thrombin generation.

Authors:  A Undas; T B Domagala; M Jankowski; A Szczeklik
Journal:  Thromb Res       Date:  1999-09-15       Impact factor: 3.944

Review 2.  Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis.

Authors:  M M Rees; G M Rodgers
Journal:  Thromb Res       Date:  1993-09-01       Impact factor: 3.944

3.  Hyperhomocysteinemia and deep-vein thrombosis. A case-control study.

Authors:  P Simioni; P Prandoni; A Burlina; D Tormene; C Sardella; V Ferrari; L Benedetti; A Girolami
Journal:  Thromb Haemost       Date:  1996-12       Impact factor: 5.249

4.  Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?

Authors:  M den Heijer; H J Blom; W B Gerrits; F R Rosendaal; H L Haak; P W Wijermans; G M Bos
Journal:  Lancet       Date:  1995-04-08       Impact factor: 79.321

Review 5.  Lipoproteins and homocyst(e)ine as risk factors for atherosclerosis: assessment and treatment.

Authors:  J J Frohlich
Journal:  Can J Cardiol       Date:  1995-05       Impact factor: 5.223

6.  Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis.

Authors:  J Selhub; P F Jacques; A G Bostom; R B D'Agostino; P W Wilson; A J Belanger; D H O'Leary; P A Wolf; E J Schaefer; I H Rosenberg
Journal:  N Engl J Med       Date:  1995-02-02       Impact factor: 91.245

7.  Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.

Authors:  M den Heijer; T Koster; H J Blom; G M Bos; E Briet; P H Reitsma; J P Vandenbroucke; F R Rosendaal
Journal:  N Engl J Med       Date:  1996-03-21       Impact factor: 91.245

8.  High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis.

Authors:  C R Falcon; M Cattaneo; D Panzeri; I Martinelli; P M Mannucci
Journal:  Arterioscler Thromb       Date:  1994-07

9.  Vitamin status and intake as primary determinants of homocysteinemia in an elderly population.

Authors:  J Selhub; P F Jacques; P W Wilson; D Rush; I H Rosenberg
Journal:  JAMA       Date:  1993-12-08       Impact factor: 56.272

Review 10.  Measurement of homocyst(e)ine in the prediction of arteriosclerosis.

Authors:  L J Fortin; J Genest
Journal:  Clin Biochem       Date:  1995-04       Impact factor: 3.281

View more
  3 in total

1.  Effect of Platelet Glycoprotein IIb/IIIa PLA2 Polymorphism on Severity of Pulmonary Thromboembolism.

Authors:  Hamid Rouhi Boroujeni; Batoul Pourgheysari; Alimohammad Hasheminia; Parnia Rouhi Boroujeni; Fatima Drees
Journal:  Tanaffos       Date:  2014

2.  Association of Homozygous Thrombophilia Polymorphisms and Venous Thromboembolism in Shahrekord, Iran.

Authors:  Hamid Rouhi-Broujeni; Batoul Pourgheysari; Ali-Mohammad Hasheminia
Journal:  Tanaffos       Date:  2016

3.  A preliminary study of inherited thrombophilic risk factors in different clinical manifestations of venous thromboembolism in central Iran.

Authors:  Ali Karimi; Marziyeh Abolhasani; Morteza Hashemzadeh-Chaleshtori; Batoul Pourgheysari
Journal:  Indian J Med Res       Date:  2015-07       Impact factor: 2.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.